News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abiomed (ABMD) Announces Clinical Progress on Symphony Program, Including Second Successful Implant in Canada


10/23/2012 8:49:25 AM

DANVERS, Mass., Oct. 23, 2012 (GLOBE NEWSWIRE) -- Abiomed,Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced clinical updates on its Symphony™ device, including the second successful human use of Symphony in Canada. The procedure was performed by Renzo Cecere, M.D., Director of the Mechanical Assist Program and Surgical Director of the Heart Failure and Heart Transplant Program at the McGill University Health Centre (MUHC) in Montreal, Quebec.

Read at GlobeNewswire


comments powered by Disqus
Abiomed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES